Insider · CIK 0001609879

Hatfield Jeffrey S.

Reports to the SEC for 7 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001609879

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-27	VIRVir Biotechnology, Inc.A Award	Director	AAward	+8,000 sh	—	—	39,806
2026-05-27	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,000
2025-05-30	VIRVir Biotechnology, Inc.A Award	Director	AAward	+8,000 sh	—	—	31,806
2025-05-30	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,000
2024-05-30	VIRVir Biotechnology, Inc.A Award	Director	AAward	+8,000 sh	—	—	23,806
2024-05-30	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,000
2023-05-22	VIRVir Biotechnology, Inc.A Award	Director	AAward	+6,027 sh	—	—	15,806
2023-05-22	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.1K sh	—	—	12,054
2022-05-23	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.8K sh	—	—	12,810
2022-05-23	VIRVir Biotechnology, Inc.A Award	Director	AAward	+6,405 sh	—	—	9,779
2021-05-21	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,748 sh	—	—	6,748
2021-05-21	VIRVir Biotechnology, Inc.A Award	Director	AAward	+3,374 sh	—	—	3,374
2021-02-04	VRDNViridian Therapeutics, Inc.\DE · Director Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2020-12-09	VIRVir Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+46.5K sh	—	—	46,500
2020-05-21	VRDNViridian Therapeutics, Inc.\DE · Stock Option (right to buy)A Award	Director	AAward	+24K sh	—	—	24,000
2020-05-06	ATYRaTYR PHARMA INC · Stock Option (right to buy)A Award	Director	AAward	+1,428 sh	—	—	1,428
2019-06-19	VRDNViridian Therapeutics, Inc.\DE · Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2019-05-08	ATYRaTYR PHARMA INC · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2019-01-22	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+525K sh	—	—	525,000
2018-06-27	VRDNViridian Therapeutics, Inc.\DE · Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2018-05-15	ATYRaTYR PHARMA INC · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2018-02-22	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+275K sh	—	—	275,000
2018-01-19	INVIVO THERAPEUTICS HOLDINGS CORP.Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2017-12-29	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+1.1M sh	—	—	1,100,000
2017-10-09	LRMRLarimar Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+550K sh	—	—	550,000
2017-05-09	ATYRaTYR PHARMA INC · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2017-04-03	ATYRaTYR PHARMA INC · Stock Option (right to buy)A Award	Director	AAward	+32K sh	—	—	32,000
2016-11-01	INVIVO THERAPEUTICS HOLDINGS CORP.Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2016-10-25	Vitae Pharmaceuticals, IncEmployee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−50K sh	$6.60	−$330K	0
2016-10-25	Vitae Pharmaceuticals, IncEmployee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−26.1K sh	$17.55	−$458K	0
2016-10-25	Vitae Pharmaceuticals, IncEmployee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−30.4K sh	$17.55	−$534K	0
2016-10-25	Vitae Pharmaceuticals, IncEmployee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−6,245 sh	$17.09	−$107K	0
2016-10-25	Vitae Pharmaceuticals, IncEmployee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−20.9K sh	$17.09	−$357K	0
2016-10-25	Vitae Pharmaceuticals, IncEmployee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−10.3K sh	$14.10	−$146K	0
2016-10-25	Vitae Pharmaceuticals, IncEmployee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−135K sh	$13.87	−$1.87M	0
2016-10-25	Vitae Pharmaceuticals, IncEmployee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−50K sh	$12.72	−$636K	0
2016-10-25	Vitae Pharmaceuticals, IncEmployee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−60K sh	$12.42	−$745K	0
2016-10-25	Vitae Pharmaceuticals, IncEmployee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−60K sh	$12.22	−$733K	0
2016-10-24	Vitae Pharmaceuticals, IncU Disposition from Tender	Director, Chief Executive Officer	UDisposition from Tender	−245K sh	$21.00	−$5.14M	244,996
2016-09-14	Vitae Pharmaceuticals, IncS Sale	Director, Chief Executive Officer	SSale	−50K sh	$20.81	−$1.04M	244,996
2016-08-15	Vitae Pharmaceuticals, IncEmployee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+60K sh	—	—	60,000
2016-04-29	Vitae Pharmaceuticals, IncA Award	Director, Chief Executive Officer	AAward	+747 sh	$6.11	+$4,564.17	294,996
2016-02-15	Vitae Pharmaceuticals, IncEmployee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+60K sh	—	—	60,000
2015-12-28	Vitae Pharmaceuticals, IncEmployee Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−26.5K sh	—	—	0
2015-12-28	Vitae Pharmaceuticals, IncM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+26.5K sh	$3.45	+$91.6K	294,249
2015-12-28	Vitae Pharmaceuticals, IncM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+26.5K sh	$3.45	+$91.6K	293,897
2015-12-23	Vitae Pharmaceuticals, IncS Sale	Director, Chief Executive Officer	SSale	−22.5K sh	$17.00	−$383K	267,360
2015-12-23	Vitae Pharmaceuticals, IncM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+5,584 sh	$3.45	+$19.3K	272,944
2015-12-23	Vitae Pharmaceuticals, IncEmployee Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−5,584 sh	—	—	0
2015-12-23	Vitae Pharmaceuticals, IncEmployee Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−16.9K sh	—	—	0

Recent filings

Accepted (ET)
May 284
Hatfield Jeffrey S.0001628280-26-038963
SEC(opens sec.gov)
Jun 24
Hatfield Jeffrey S.0001628280-25-028892
SEC(opens sec.gov)
Jun 34
Hatfield Jeffrey S.0001628280-24-026193
SEC(opens sec.gov)
May 244
Hatfield Jeffrey S.0001209191-23-031841
SEC(opens sec.gov)
May 254
Hatfield Jeffrey S.0001209191-22-031949
SEC(opens sec.gov)
May 254
Hatfield Jeffrey S.0001209191-21-035706
SEC(opens sec.gov)
Feb 84
Hatfield Jeffrey S.0000899243-21-005208
SEC(opens sec.gov)
Dec 114
Hatfield Jeffrey S.0001209191-20-062955
SEC(opens sec.gov)
May 224
Hatfield Jeffrey S.0001209191-20-031843
SEC(opens sec.gov)
May 84
Hatfield Jeffrey S.0001209191-20-027974
SEC(opens sec.gov)
Jun 214
Hatfield Jeffrey S.0001209191-19-038561
SEC(opens sec.gov)
May 104
Hatfield Jeffrey S.0001209191-19-029039
SEC(opens sec.gov)
Jan 244
Hatfield Jeffrey S.0000899243-19-001927
SEC(opens sec.gov)
Jun 284
Hatfield Jeffrey S.0001209191-18-039879
SEC(opens sec.gov)

Companies

Address

C/O VIR BIOTECHNOLOGY, INC. 1800 OWENS STREET, SUITE 900

SAN FRANCISCO, CA, 94158